The Electrospinning Company

The Electrospinning Company is a nanofibre innovation and development company that uses the electrospinning process to manufacture nanofibre structures and scaffolds for the biotech industry, and in particular the rapidly emerging stem cell therapy sector. Stem cells require optimum growing conditions both in labs and in humans and, uniquely, the Electrospinning Company is able to offer its customers both a better scaffold for laboratory use in the discovery phase of new stem cell therapies and also a route to then getting those therapies into patients by partnering with customers to develop specialized implantable nanofibre devices.

Status current

Associated Fund UK Innovation & Science Seed Fund

Sector Medical / Biotechnology


Associated Team Members

Relevant News

IKC/Regener8 – Leeds, UK – 29th June

Rob McKean will attend IKC & Regener8 Annual Conference 2018 Date: June 29, 2018 @...

read more

A new era in Regenerative Medicine: accelerating research from bench...

TECL’s CEO Ann Kramer will be speaking at this year’s Innovation Forum event on...

read more

Quality ISO 13485:2016 recertification

Update to ISO 13485:2016 standard and re-certification. The Electrospinning Company achieved ISO 13485:2003 certification in 2015...

read more

Electrospinning for drug delivery – London – 18th April 2018

The UK-China Mini-Symposium on Electrospinning for Drug Delivery will bring together researchers from both...

read more

Materials Research Exchange – London – 13th March 2018

Ann Kramer will be at The Materials Research Exchange event at the Design Centre,...

read more

ESB – Maastricht, Netherlands – Sept 9-13, 2018

We will be at the 29th European Conference on Biomaterials from September 9-13 in...

read more

More Companies in Medical / Biotechnology

Your browser is out-of-date!

Update your browser to view this website correctly.Update my browser now